# Entrada Therapeutics, Inc.: Form 8-K, filed Sep 21, 2023

- Company: [Entrada Therapeutics, Inc.](/companies/trda.md) (CIK 1689375)
- Form: 8-K
- Filed: 2023-09-21
- Accepted by EDGAR: Sep 21, 2023, 07:09 ET
- Period: 2023-09-21
- Accession: 0001689375-23-000068
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1689375/000168937523000068/trda-20230921.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1689375/000168937523000068/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1689375/000168937523000068/trda-20230921.htm

Filed Sep 21, 2023.
Source: SEC EDGAR, the filing index for accession 0001689375-23-000068. Last ingested by Listed: Nov 5, 2026, 11:57 ET. No prices; not investment advice.